Multidisciplinary Association for Psychedelic Studies
Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana
The Beckley Foundation is one of the few organisations in the world that initiates and directs scientific research into cannabis and the psychedelics. Over 50 papers, arranged here in reverse chronological order, have been published in influential scientific journals as a result of Amanda Feilding’s collaborative projects.
Center for Psychedelic & Consciousness Research
Johns Hopkins is deeply committed to exploring innovative treatments for patients.
Current projects include psilocybin and smoking cessation, psilocybin and depression study, psilocybin and alzheimer’s disease study, psilocybin and anorexia nervosa study, religious professionals study, insight survey.
California Institute of Integral Studies
Center for Psychedelic Therapies and Research
Imperial College London
Center for Psychedelic Research
Funded by more than £3 million from five founding donors, the Imperial Centre for Psychedelic Research builds on over a decade of pioneering work in this area carried out at Imperial College London, including a clinical trial that has kick-started global efforts to develop psilocybin therapy into a licensed treatment for depression.
Led by Dr Robin Carhart-Harris, the Centre focuses on two main research themes: the use of psychedelics in mental health care; and as tools to probe the brain’s basis of consciousness. It will also investigate their potential for treating other conditions, including anorexia.
The Centre aims to develop a research clinic that could help to gather additional clinical evidence and become a prototype for the licensed psychedelic care facilities of the future. It represents a watershed moment for psychedelic science, symbolic of its now mainstream recognition. Psychedelics are set to have a major impact on neuroscience and psychiatry in the coming years, and the Centre operates at the forefront of one of the most exciting areas in medical science.
Heffter Research Institute
The Heffter Research Institute promotes research of the highest scientific quality with the classic hallucinogens and related compounds (sometimes called psychedelics) in order to contribute to a greater understanding of the mind leading to the improvement of the human condition, and to alleviate suffering.